Giovedì, 18 Gennaio 2018 17:44

1st International Workshop on Tumor evolution and heterogeneity of the cancer genome: challenges and opportunities for precision medicine

Clonal selection is a major mechanism through which tumor cells succeed in adapting to severe envi-ronmental changes and maintain their fitness.
This Darwinian process of tumor evolution is bound to generate heterogeneous profiles of driver mutations within a single lesion and across different lesions in any individual patient (intra-tumor heterogeneity).
On the other hand, tumors with the same histo-type isolated from different patients may diverge substantially in their profile of genetic drivers (inter-tumor heterogeneity) and yet share relatively homogeneous gene expression profiles and, predicta-bly, the unique biological and clinical features inherent to those shared transcriptional programs. The-se compound patterns of tumor heterogeneity pose a potential challenge to a notion of precision can-cer medicine predicated solely upon therapeutic targeting of a unique genetic driver in any individual patient.
The aim of this workshop is to critically appraise these emerging issues by a) presenting a sta-te of the art view of cancer genomic heterogeneity; b) illustrating how this knowledge can be effecti-vely leveraged for pharmacological tumor targeting in the clinic; c) showcasing examples of how com-putational systems biology and functional genomics can be exploited for identifying novel functional dependencies in cancer cells.

| Download Program |

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our privacy policy.

I accept cookies from this site.

EU Cookie Directive Module Information